- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.07. | Non-profit DNDi preps phase 3 trials for dengue antibody | ||
| 10.07. | Bausch + Lomb drug fails in glaucoma, but a new use beckons | ||
| 10.07. | Roche abandons two Huntington's drug candidates | ||
| 10.07. | Bayer gets €3bn from Apollo for contraceptives unit stake | ||
| 09.07. | Moderna's mResvia gets shot in the arm from EU contract | ||
| 09.07. | Keenova eyes Xiaflex as first drug for plantar fibromatosis | ||
| 09.07. | GSK ends dementia alliance with Alector after setbacks | ||
| 09.07. | NICE aims to cut funding for Amgen lung cancer drug Lumykras | ||
| 09.07. | AZ, Ionis hit by unexpected Wainua trial failure | ||
| 09.07. | UK first in Europe to clear Boehringer's IPF drug Jascayd | ||
| 08.07. | Aureka offers open-source AI module for drug discovery | ||
| 08.07. | AZ pays $200m upfront for Sino Bio COPD drug | ||
| 08.07. | EU seeks advice on Sanofi's response to mismarketing claim | ||
| 08.07. | Otsuka's Voyxact faces rival as FDA okays Vera IgAN drug | ||
| 08.07. | Kailera's big obesity reveal puts pressure on shares | ||
| 07.07. | Obesity biotech Kalohexis files confidential IPO | ||
| 07.07. | Island Pharma drug cleared for Bundibugyo Ebola use | ||
| 07.07. | With measles cases rising, UK launches vaccination drive | ||
| 07.07. | NICE backs NHS use of non-invasive endometriosis tests | ||
| 07.07. | Vertex buys Crinetics for $10bn in endocrinology drive | ||
| 06.07. | AI-powered triage is coming to the NHS App | ||
| 06.07. | Roche looks to Astex in $515m breast cancer deal | ||
| 06.07. | Novartis snaps up UK ADC developer Myricx Bio | ||
| 06.07. | Olympic cyclist Chris Hoy praises cancer charity campaign | ||
| 03.07. | Scribe Therapeutics joins the IPO queue |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.